333
Views
1
CrossRef citations to date
0
Altmetric
Review

A Call to Action by the Italian Mesotherapy Society on Scientific Research

ORCID Icon, , , , , ORCID Icon, ORCID Icon, , , , , ORCID Icon, ORCID Icon, , , ORCID Icon, , & show all
Pages 3041-3047 | Published online: 12 Jul 2021
 

Abstract

Mesotherapy (local intradermal therapy, LIT) is a technique used to slowly spread drugs in tissues underlying the site of injection to prolong the pharmacological effect with respect to intramuscular injection. Recommendations for proper medical use of this technique have been made for pain medicine and rehabilitation, chronic venous disease, sport medicine, musculoskeletal disorders, several dermatological conditions, skin ageing, and immune-prophylaxis. Although mesotherapy is considered a valid technique, unresolved questions remain, which should be answered to standardize methodology and dosing regimen as well as to define the right indications in clinical practice. New randomized controlled trials are needed to test single products (dose, frequency of administration, efficacy and safety). Even infiltration of substances for dermo-cosmetic purposes must be guided by safety and efficacy tests before being proposed by mesotherapy. In this article, we put forth a preclinical and clinical research plan and a health technology assessment as a call to action by doctors, researchers and scientific societies to aid national health authorities in considering mesotherapy for prevention, treatment and rehabilitation paths.

Video abstract

Read the transcript

Watch the video on Vimeo

Point your SmartPhone at the code above. If you have a QR code reader the video abstract will appear. Or use:

https://youtu.be/bIuRhGQsUjs

Video abstractRead the transcriptWatch the video on VimeoPoint your SmartPhone at the code above. If you have a QR code reader the video abstract will appear. Or use:https://youtu.be/bIuRhGQsUjs

Acknowledgment

We thank Lexis for revising the English version of this article.

Disclosure

Prof. Dr. Silvia Natoli reports personal fees from Grunenthal Italia, grants from Grunenthal Italia, personal fees from Mylan, personal fees from Angelini, personal fees from Sandoz, outside the submitted work. All the other authors declare no conflicts of interest.

Additional information

Funding

This article was not supported with funding.